To map target transcripts by which IGF2BP2 promotes HCC progression, we first performed immunoprecipitation sequencing (MeRIP-seq) in HepG2 cells with stable METTL3 knockdown. This evidence concerns the gene METTL3 and hepatocellular carcinoma.